{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:32:54Z","timestamp":1788993174695,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4886,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1053\/seiz.1999.0372","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T17:49:59Z","timestamp":1027878599000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation"],"prefix":"10.1053","volume":"9","author":[{"given":"Barry E","family":"Gidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill Kerrick","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex S","family":"Lott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rutecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/seiz.1999.0372_RF1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1111\/j.1528-1157.1996.tb06039.x","article-title":"The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps","volume":"37","author":"Mattson","year":"1996","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1528-1157.1998.tb01163.x","article-title":"Intractable epilepsy in a population-based series of mentally retarded children","volume":"39","author":"Steffenburg","year":"1998","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archneur.1996.00550090114017","article-title":"Psychiatric disorders in children and adolescents with mental retardation and active epilepsy","volume":"53","author":"Steffenburg","year":"1996","journal-title":"Archives of Neurology"},{"key":"10.1053\/seiz.1999.0372_RF4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0920-1211(96)00072-1","article-title":"A decade of modern epilepsy therapy in institutionalized mentally retarded patients","volume":"25","author":"Pellock","year":"1996","journal-title":"Epilepsy Research"},{"key":"10.1053\/seiz.1999.0372_RF5","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1177\/0883073897012001091","article-title":"Meeting the challenge of epilepsy in persons with multiple handicaps","volume":"12 (Suppl. 1)","author":"Sunder","year":"1997","journal-title":"Journal of Child Neurology"},{"key":"10.1053\/seiz.1999.0372_RF6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1345\/aph.18299","article-title":"The new generation of anti-epileptic drugs: unresolved questions","volume":"32","author":"Graves","year":"1998","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1053\/seiz.1999.0372_RF7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","article-title":"An active-control trial of lamotrigine monotherapy for partial seizures","volume":"51","author":"Gilliam","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/seiz.1999.0372_RF8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox\u2013Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/seiz.1999.0372_RF9","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1177\/0883073897012001071","article-title":"Use of lamotrigine in Lennox\u2013Gastaut and related epilepsy syndromes","volume":"12 (Suppl. 1)","author":"Dulac","year":"1997","journal-title":"Journal of Child Neurology"},{"key":"10.1053\/seiz.1999.0372_RF10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2008-1073041","article-title":"Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits","volume":"25","author":"Uvebrant","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1053\/seiz.1999.0372_RF13","first-page":"162","article-title":"Efficacy of lamotrigine in the developmentally disabled (abstract)","volume":"37","author":"King","year":"1996","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1059-1311(97)80066-0","article-title":"A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities","volume":"6","author":"Bhaumik","year":"1997","journal-title":"Seizure"},{"key":"10.1053\/seiz.1999.0372_RF15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0387-7604(97)00046-6","article-title":"Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial","volume":"19","author":"Coppola","year":"1997","journal-title":"Brain Development"},{"key":"10.1053\/seiz.1999.0372_RF16","first-page":"130","article-title":"Long-term follow-up on lamotrigine in treatment of epilepsy in the mentally retarded","volume":"39","author":"Sorensen","year":"1998","journal-title":"Epilepsia (Abstract)"},{"key":"10.1053\/seiz.1999.0372_RF17","first-page":"130","article-title":"Effects of Lamictal\u00ae\/adjunctive therapy in mentally retarded patients with epilepsy: An interim analysis","volume":"39","author":"McKee","year":"1998","journal-title":"Epilepsia (Abstract)"},{"key":"10.1053\/seiz.1999.0372_RF18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1528-1157.1999.tb00831.x","article-title":"Adding lamotrigine to valproate: incidence of rash and other adverse effects","volume":"40","author":"Faught","year":"1999","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1157.1998.tb01373.x","article-title":"Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.1999.0372_RF21","first-page":"254","article-title":"A typical presentation of carbamazepine toxicity from pharmacodynamic interaction with lamotrigine in people with learning disability","volume":"40 (Suppl. 2)","author":"Besag","year":"1999","journal-title":"Epilepsia (Abstract)"},{"key":"10.1053\/seiz.1999.0372_RF22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/bmj.313.7066.1158","article-title":"Drug trials in epilepsy","volume":"313","author":"Mignot","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.1999.0372_RF23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Research"},{"key":"10.1053\/seiz.1999.0372_RF24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1157.1999.tb00832.x","article-title":"The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction","volume":"40","author":"Pisani","year":"1999","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131199903722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131199903722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:25:00Z","timestamp":1761009900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131199903722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S1059131199903722"],"URL":"https:\/\/doi.org\/10.1053\/seiz.1999.0372","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/seiz.1999.0372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 BEA Trading, Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}